Ribonova Inc
Advertisement
Ribonova Inc, located in Wynnewood, PA, is dedicated to helping patients suffering from serious rare diseases by discovering and developing novel medicines to treat their conditions. The company focuses on addressing the significant burden of mitochondrial disease, which affects approximately 75,000 people in the United States.
Ribonova's lead product candidate, R007, is a Phase 2 ready small molecule designed for the treatment of inherited mitochondrial disease. Through their innovative research and development efforts, Ribonova aims to make a meaningful impact on the lives of those affected by this devastating condition.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement
